APA (7th ed.) Citation

K, K., Y, S., DA, S., S, S., G, J., CG, E., & RJ, P. (2026). LncRNA-HLX-2-7/HLX axis-dependent metabolic reprogramming drives cancer progression in group 3 medulloblastoma. Acta neuropathologica communications, 14(1), . https://doi.org/10.1186/s40478-026-02266-2

Chicago Style (17th ed.) Citation

K, Katsushima, Sanada Y, Scott DA, Stapleton S, Jallo G, Eberhart CG, and Perera RJ. "LncRNA-HLX-2-7/HLX Axis-dependent Metabolic Reprogramming Drives Cancer Progression in Group 3 Medulloblastoma." Acta Neuropathologica Communications 14, no. 1 (2026). https://doi.org/10.1186/s40478-026-02266-2.

MLA (9th ed.) Citation

K, Katsushima, et al. "LncRNA-HLX-2-7/HLX Axis-dependent Metabolic Reprogramming Drives Cancer Progression in Group 3 Medulloblastoma." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, https://doi.org/10.1186/s40478-026-02266-2.